Heregulin selectively upregulates vascular endothelial growth factor secretion in cancer cells and stimulates angiogenesis (Q40865263)

24 September 2017

Heregulin selectively upregulates vascular endothelial growth factor secretion in cancer cells and stimulates angiogenesis (English)

1 reference

24 September 2017

0 references

Yen L

1

1 reference

24 September 2017

You XL

2

1 reference

24 September 2017

Al Moustafa AE

3

1 reference

24 September 2017

Batist G

4

1 reference

24 September 2017

Hynes NE

5

1 reference

24 September 2017

Mader S

6

1 reference

24 September 2017

Meloche S

7

1 reference

24 September 2017

Alaoui-Jamali MA

8

1 reference

24 September 2017

language of work or name

English

0 references

publication date

1 July 2000

1 reference

24 September 2017

1 reference

24 September 2017

19

1 reference

24 September 2017

31

1 reference

24 September 2017

3460-3469

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.onc.1203685

24 September 2017

0 references

cites work

Targets of v-myc tumorigenesis in the avian embryo depend on time and not on site of retroviral infection

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203685

7 January 2021

The ErbB signaling network in embryogenesis and oncogenesis: signal diversification through combinatorial ligand-receptor interactions

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203685

7 January 2021

Oncogenic H-ras stimulates tumor angiogenesis by two distinct pathways

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203685

7 January 2021

Estrogen-dependent, tamoxifen-resistant tumorigenic growth of MCF-7 cells transfected with HER2/neu

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203685

7 January 2021

Antiintegrin alpha v beta 3 blocks human breast cancer growth and angiogenesis in human skin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203685

7 January 2021

Neuregulin-2, a new ligand of ErbB3/ErbB4-receptor tyrosine kinases

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203685

7 January 2021

Ligands for ErbB-family receptors encoded by a neuregulin-like gene

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203685

7 January 2021

Suppression of glioblastoma angiogenicity and tumorigenicity by inhibition of endogenous expression of vascular endothelial growth factor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203685

7 January 2021

Regulation of VEGF/VPF expression in tumor cells: consequences for tumor growth and metastasis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203685

7 January 2021

Growth factors in development, transformation, and tumorigenesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203685

7 January 2021

The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203685

7 January 2021

Comparison of VEGF, VEGF-B, VEGF-C and Ang-1 mRNA regulation by serum, growth factors, oncoproteins and hypoxia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203685

7 January 2021

Normoxic and hypoxic regulation of vascular endothelial growth factor (VEGF) by astrocytoma cells is mediated by Ras.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203685

7 January 2021

Lovastatin and tumor necrosis factor-alpha exhibit potentiated antitumor effects against Ha-ras-transformed murine tumor via inhibition of tumor-induced angiogenesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203685

7 January 2021

The vascular endothelial growth factor family of polypeptides

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203685

7 January 2021

Molecular and biological properties of the vascular endothelial growth factor family of proteins

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203685

7 January 2021

Molecular mechanisms of angiogenesis: fibroblast growth factor signal transduction.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203685

7 January 2021

Single-chain antibody-mediated intracellular retention of ErbB-2 impairs Neu differentiation factor and epidermal growth factor signaling

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203685

7 January 2021

ErbB-2, the preferred heterodimerization partner of all ErbB receptors, is a mediator of lateral signaling

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203685

7 January 2021

Both v-Ha-Ras and v-Raf stimulate expression of the vascular endothelial growth factor in NIH 3T3 cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203685

7 January 2021

Neuregulin-4: a novel growth factor that acts through the ErbB-4 receptor tyrosine kinase

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203685

7 January 2021

Identification of heregulin, a specific activator of p185erbB2

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203685

7 January 2021

Dormancy of micrometastases: balanced proliferation and apoptosis in the presence of angiogenesis suppression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203685

7 January 2021

A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203685

7 January 2021

Vascular endothelial growth factor-related protein: a ligand and specific activator of the tyrosine kinase receptor Flt4

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203685

7 January 2021

Post-transcriptional regulation of vascular endothelial growth factor by hypoxia.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203685

7 January 2021

Isolation of a human placenta cDNA coding for a protein related to the vascular permeability factor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203685

7 January 2021

A receptor tyrosine kinase cDNA isolated from a population of enriched primitive hematopoietic cells and exhibiting close genetic linkage to c-kit

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203685

7 January 2021

p42/p44 MAP kinase module plays a key role in the transcriptional regulation of the vascular endothelial growth factor gene in fibroblasts

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203685

7 January 2021

Hypoxic induction of human vascular endothelial growth factor expression through c-Src activation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203685

7 January 2021

Vascular endothelial growth factor B, a novel growth factor for endothelial cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203685

7 January 2021

The vascular endothelial growth factor (VEGF) isoforms: differential deposition into the subepithelial extracellular matrix and bioactivity of extracellular matrix-bound VEGF.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203685

7 January 2021

Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203685

7 January 2021

VEGF145, a secreted vascular endothelial growth factor isoform that binds to extracellular matrix

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203685

7 January 2021

Specificity within the EGF family/ErbB receptor family signaling network

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203685

7 January 2021

Hypoxia-induced metastasis of human melanoma cells: involvement of vascular endothelial growth factor-mediated angiogenesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203685

7 January 2021

Vascular endothelial growth factor expression in human neuroblastoma: up-regulation by hypoxia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203685

7 January 2021

Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203685

7 January 2021

Halting angiogenesis suppresses carcinoma cell invasion

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203685

7 January 2021

Stabilization of vascular endothelial growth factor mRNA by hypoxia and hypoglycemia and coregulation with other ischemia-induced genes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203685

7 January 2021

Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203685

7 January 2021

Vascular endothelial growth factor: a new member of the platelet-derived growth factor gene family

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203685

7 January 2021

Vascular endothelial growth factor in human glioma cell lines: induced secretion by EGF, PDGF-BB, and bFGF.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203685

7 January 2021

Vascular permeability factor/vascular endothelial growth factor (VPF/VEGF) delays and induces escape from senescence in human dermal microvascular endothelial cells.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203685

7 January 2021

Molecular cloning of a novel vascular endothelial growth factor, VEGF-D

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203685

7 January 2021

Regulation of cellular response to cisplatin-induced DNA damage and DNA repair in cells overexpressing p185(erbB-2) is dependent on the ras signaling pathway

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203685

7 January 2021

Dual effect of erbB-2 depletion on the regulation of DNA repair and cell cycle mechanisms in non-small cell lung cancer cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203685

7 January 2021

Neuregulin-3 (NRG3): a novel neural tissue-enriched protein that binds and activates ErbB4

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203685

7 January 2021

Transformation of NIH 3T3 cells by HER3 or HER4 receptors requires the presence of HER1 or HER2

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203685

7 January 2021

Identifiers

DOI

10.1038/SJ.ONC.1203685

1 reference

Dimensions Publication ID

24 September 2017

0 references

1 reference